Abstract:Alopecia is a dermatological disorder, commonly known as hair loss, which affects up to half of the Caucasian male population by middle age, and almost all (95%) Caucasian men by old age. Considering that alopecia affects so many people and that there is currently no scientifically proven treatment with few side effects, new drug-delivery systems able to improve alopecia therapy are urgently required. With this purpose in mind, the present study aimed to develop lipid nanoparticles (nanostructured lipid carriers) with the ability to incorporate and deliver anti-alopecia active compounds (minoxidil and finasteride) into the dermis and hair follicles. Lipid nanoparticles, prepared by ultrasonication method, showed mean particle sizes around 200 nm, which is sufficient for reaching the dermis and hair follicles, and zeta potential values around -30 mV, which indicates good physical stability. Over 28 days of storage, no significant variations in these parameters were observed, which indicates that all nanoformulations are stable in storage over that period. Cryo-scanning electron microscope measurements showed that all the lipid nanoparticles exhibited a spherical shape and a smooth surface regardless of their composition. Differential scanning calorimetry studies allowed the determination of phase transition temperatures and confirmed the recrystallization of the lipid nanoparticles (recrystallization index between 11% and 86%). A high loading efficiency was achieved for finasteride (between 70% and 90%), while less than 30% was achieved for minoxidil nanoparticles, over 28 days. Controlled release assays in physiological conditions demonstrated that nanoparticles loaded with minoxidil yielded a prolonged release, as desired. Penetration assays through pig ear skin demonstrated that nanoparticles loaded with minoxidil and finasteride had low levels of penetration. These results suggest that the proposed novel formulation presents several good characteristics indicating their suitability for dermal delivery of anti-alopecia active compounds.

Biomaterials for Treatment of Baldness

Dissolving microneedles for alopecia treatment

Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies

Novel drug delivery approaches for the management of hair loss

Medical Treatment for Androgenetic Alopecia

Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system

Drug discovery for alopecia: gone today, hair tomorrow

Medical and procedural treatment of androgenetic alopecia - Where are we?

Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options

Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women

A review of the treatment of male pattern hair loss

Preparation and Optimization of Garlic Oil/Apple Cider Vinegar Nanoemulsion Loaded with Minoxidil to Treat Alopecia

Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia

Management of androgenic alopecia: a systematic review of the literature

Microneedle Delivery Platform Integrated with Codelivery Nanoliposomes for Effective and Safe Androgenetic Alopecia Treatment

Small molecule agents against alopecia: Potential targets and related pathways

Towards a molecular understanding of hair loss and its treatment

Medicinal and cosmetic products used in treatment of hair loss

Potential application of PBM use in hair follicle organoid culture for the treatment of androgenic alopecia

Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia

Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia